HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer

Ebelt Mark H.

首页> 外文期刊>American Family Physician >HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer

【24h】

HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer

机译：HPV疫苗，特别是在17岁之前，与侵袭性宫颈癌的大量减少有关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《American Family Physician》 |2021年第5期|共1页
作者
Ebelt Mark H.;
展开▼
作者单位

Univ Georgia Athens GA 30602 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. The Changes in the Awareness of Cervical Cancer Prevention and the Acceptability of HPV Vaccines among Women after Their Introduction in China [J] . MA Quan Fu, WU Xu Feng, GUO Yu Lin, 生物医学与环境科学（英文版） . 2019,第011期
2. Prevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province [J] . Shang-ying Hu, Hui Li, You-lin Qiao, 中国癌症研究（英文版） . 2011,第001期
3. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. [J] . Jenkins D Gynecologic Oncology: An International Journal . 2008,第3Suppla1期

机译：HPV-16 / 18 AS04辅助宫颈癌疫苗对致癌性HPV的交叉保护综述：病毒学和临床终点的重要性及其对预防宫颈癌的大规模疫苗接种的意义。
4. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. [J] . Gynecologic Oncology: An International Journal . 2008,第3Suppla1期

机译：HPV-16 / 18 AS04辅助宫颈癌疫苗对致癌性HPV的交叉保护综述：病毒学和临床终点的重要性及其对预防宫颈癌的大规模疫苗接种的意义。
5. Chapter 17: Second generation HPV vaccines to prevent cervical cancer [J] . Schiller JT, Nardelli-Haefliger D Vaccine . 2006,第Suppla3期

机译：第17章：预防宫颈癌的第二代HPV疫苗
6. Structural Characterization of L1 Virus-Like Particles Used as Antigens in Cervarix~(TM) , the HPV-16 and HPV-18 Vaccine against Cervical Cancer [C] . M. Deschuyteneer, A. Miseur Microscopy and microanalysis.;Microscopy and microanalysis. . -1

机译：用于宫颈癌的Cervarix〜（TM），HPV-16和HPV-18疫苗中用作抗原的L1病毒样颗粒的结构表征
7. The Prevalence of HPV Associated Disease in Women Under Age 21: Who will be missed under the new cervical cancer screening guidelines? [D] . DeCew, Amanda E. 2012

机译：21岁以下女性的HPV相关疾病患病率：新的宫颈癌筛查指南将遗漏谁？
8. Knowledge/attitude/practices of HPV cervical cancer willingness to participate in vaccine trial in preparation for HIV HPV vaccine trials in Mali [O] . D Poole, K Tracy, L Levitz, 2012

机译：HPV和宫颈癌的知识/态度/做法愿意参加疫苗试验为马里的HIV和HPV疫苗试验做准备
9. Development of a prophylactic vaccine effective against a broader spectrum of HPVs associated with cervical cancer and basic research on therapeutic HPV vaccine for cervical cancer [O] . 吉川裕之 2010

机译：能够有效预防与宫颈癌相关的多种HPV的预防性疫苗的开发以及宫颈癌治疗性HPV疫苗的基础研究
10. Knowledge and attitudes about Human Papilloma Virus (HPV) vaccination and cervical cancer screening among women in rural Uganda (POSTPRINT). [R] . Nkonwa, I. H., D'Onofrio, M. J., Ngonzi, J., 2016

机译：乌干达农村妇女人乳头瘤病毒（HpV）疫苗接种和宫颈癌筛查的知识和态度（pOsTpRINT）。

HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer

著录项

相似文献

相关主题

期刊订阅